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INTRODUCTION:  With  the  increase  of thoracic  aortic  aneurysm  surgery  and  thoracic  endovascular  aortic
repair,  secondary  aortoesophageal  fistula  (AEF)  has  been  reported.  However,  the treatment  strategy  for
AEF remains  controversial.
PRESENTATION  OF  CASES:  Four  patients  who  had  undergone  prosthetic  aortic  replacement  for  thoracic
aortic  aneurysm  4–36  months  previously,  were  hospitalized  with  sepsis-like  symptoms.  They  were  diag-
nosed  with  aortic  prosthetic  graft  infection  after  computed  tomography  revealed  ectopic  gas  around  the
prosthesis.  After that,  esophagogastroduodenoscopy  revealed  an esophageal  perforation,  so  we  diagnosed
AEF. They  received  medication  and  stepwise  surgery;  1  patient  was  discharged,  2  remain  hospitalized,
and  1 died.
DISCUSSION:  Some  reports  have suggested  that combined  surgery  provides  better  outcomes  for  AEF.
Infection  may  be  controlled  by esophagectomy  and  antibiotic  treatment,  so  prosthesis  replacement  issophagectomy not always  necessary.  However,  we should  note  that  infection  between  a  prosthetic  graft  and  the  native
aorta  brings  a danger  of pseudoaneurysm  of the  anastomosis.
CONCLUSION:  Based  on  our  experience  we  conclude  that  surgery  performed  stepwise  along  with  infection
control  and  general  health  improvement  is  a valid  treatment  strategy  for secondary  AEF after  prosthetic
aortic  replacement.
©  2020  The  Authors.  Published  by  Elsevier  Ltd  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
 articaccess
. Introduction
Aortoesophageal fistula (AEF) may  be primary or secondary.
ith the increase of thoracic aortic aneurysm surgery and tho-
acic endovascular aortic repair (TEVAR), secondary AEF has been
eported [1–3]. Some treatment strategies for AEF have been pre-
ented [4–9]. However, there have been few reports with multiple
ases of secondary AEF after prosthetic aortic replacement, so the
reatment strategies remain controversial. In our facility, we have
ttempted a strategy including performing surgery stepwise for
 cases of AEF after prosthetic aortic replacement, and we herein
eport them. This work has been reported in line with the PROCESS
riteria [10].∗ Corresponding author at: Department of Cardiovascular Surgery, Shiga Univer-
ity  of Medical Science, Setatsukinowa-cho, Otsu, Shiga, Japan.
E-mail address: m motoeno@yahoo.co.jp (M.  Enomoto).
ttps://doi.org/10.1016/j.ijscr.2020.08.021
210-2612/© 2020 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group
rg/licenses/by/4.0/).le under  the CC  BY  license  (http://creativecommons.org/licenses/by/4.0/).
2. Case presentation
2.1. Brief case histories before staged surgeries
Case 1: an 83-year-old man. Around 28 months after total arch
replacement (TAR), he suffered fever and shivering. Prosthetic graft
infection was diagnosed when computed tomography (CT) showed
ectopic gas around the prosthesis. After 17 days in hospital, an
infected pseudoaneurysm at the distal anastomosis of TAR and a
resulting aortobronchial fistula were found. Emergency descending
aorta replacement (DAR) was performed, and he was  saved. Nine
days after DAR, an air leak from the chest drain was  found, and
AEF was  confirmed 2 days later by esophagogastroduodenoscopy
(EGD).
Case 2: a 72-year-old man. Four months after TAR, he suffered
fever and shivering. Prosthetic graft infection was diagnosed by CT.
After 10 days in hospital a diagnosis of AEF was confirmed by EGD.Case 3: an 88-year-old woman. Around 36 months after TAR, a
pseudoaneurysm at the distal anastomosis of TAR and a resulting
left main bronchial obstruction occurred. Emergency TEVAR was
 Ltd. This is an open access article under the CC BY license (http://creativecommons.



























Fig. 1. Computed tomography of the chest revealed ectopic gas a
erformed, and she was saved. She developed a fever 18 days after
EVAR, and prosthetic graft infection was diagnosed by CT (Fig. 1).
 diagnosis of AEF was confirmed by EGD (Fig. 2), 31 days after
EVAR.
Case 4: a 79-year-old woman. Around 17 months after DAR, she
ad fever, and prosthetic graft infection was diagnosed by CT. On
er 2nd day in hospital, an infected pseudoaneurysm at the proxi-
al  site of DAR and a resulting aortobronchial fistula were found.
mergency TAR was performed, and she was saved, but 48 days
ater she suffered fever and shivering. Reoccurrence of prosthetic
raft infection was diagnosed by CT, and AEF was confirmed by EGD
0 days after TAR.
Detailed description of our cases with AEF are shown in Table 1.
.2. Our staged treatment strategy is as follows
First-stage surgery is esophagectomy, esophagostomy, and
nterostomy. The first operation involves resection of the esopha-
us, formation of an oral side esophagostoma on the left side of the
eck, and jejunostomy of the feeding route.
Second-stage surgery is additional cardiovascular surgery if
eeded. In case 2, the distal anastomotic site of the TAR was con-
idered to be the main infection site associated with the fistula, so
EVAR was performed for reinforcement. In case 4, as in case 1, the
ain site of infection associated with the fistula was at the junction
etween two prostheses; in this case, between the proximal end of
he DAR (installed 17 months earlier) and the distal end of the TAR
installed 50 days earlier). However, infection also caused a pseu-
oaneurysm at the distal anastomosis of the DAR, so in stage 2 the
AR was performed again. In case 1 and 3, no additional surgery
as done there. the prosthesis, which appears continuous from the esophagus.
Third-stage surgery is esophageal reconstruction. This was per-
formed in cases 1, 2, and 3, after improvement of general conditions
and infection findings. In those 3 cases, a gastric tube was  formed
using the patient’s stomach to replace the esophagus, in an antetho-
racic route.
2.3. Outcomes after staged surgery
Case 1 survived the third-stage surgery, but suffered hypercal-
cemia associated with a tumor and renal failure, and died on day
224 of hospitalization. Case 2 recovered and was  discharged from
our hospital on day 227. In case 3, after esophagus reconstruction,
suture failure occurred between the esophagus and the gastric tube,
and formed a skin fistula. As of day 216 of hospitalization, she has
received conservative treatment for that problem. Case 4 survived
after second-stage surgery, but has continued to receive treatment
for infection and chronic disseminated intravascular coagulation.
As of day 160 of hospitalization, esophageal reconstruction has not
been achieved.
3. Discussion
All the AEF cases described here occurred after prosthetic
aortic replacement for thoracic aortic aneurysm. These fistulae
were formed at the contact between the distal anastomotic site
of TAR and the middle thoracic esophagus. One possibility is
that the esophagus fistula, perhaps caused by ischemic necrosis
with compression (that is, with mechanical stimulation or irrita-
tion) or operative technique, leaked esophageal contents onto the
aortic prosthesis, caused infection there. Alternatively aortic pros-
thetic infection might have occurred first, perhaps due to caries,
hemodialysis, or invasive treatment, and that infection led to the
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Fig. 2. Esophagogastroduodenoscopy showed an aortoesophageal fistula (white arrows) in the esophagus.
Table 1
Detailed description of our cases with aortoesophageal fistula.
Case 1 2 3 4
Age  83 72 88 79
Sex  male male female female
Fistula mechanism secondary secondary secondary secondary
Site  of fistula middle thoracic esophagus
(28 cm from incisors)
middle thoracic esophagus
(30 cm from incisors)
middle thoracic esophagus
(28 cm from incisors)
middle thoracic esophagus
(28 cm from incisors)
Previous procedure TAR (previous operation)
DAR (this hospitalization)





Initial  symptoms air leak from drain fever, shivering fever fever, shivering
Times  till symptoms 28 months after TAR 9 days
after DAR
4 months after TAR 36 months after TAR 18
days after TEVAR
17 months after DAR 50
days after TAR
Interval  from initial
symptoms to diagnosis
2 days 10 days 13 days 2 days
Interval from diagnosis to
first operation
0 day 2 days 1 day 1 day
First-stage esophagectomy esophagectomy esophagectomy esophagectomy
Result survival survival survival survival
Interval between stages – 37 days – 28 days
Second-stage – TEVAR – Redo DAR
Result  survival survival survival survival
Interval between stages 86 days 61 days 103 days 79 days
Third-stage esophageal reconstruction esophageal reconstruction esophageal reconstruction treatment of infection and
DIC
result survival survival survival
Interval between stages 109 days 117 days 81 days
Fourth-stage death discharge waiting for closure of
cutaneous fistula
TAR: total arch replacement; DAR: descending aorta replacement; TEVAR: thoracic endovascular aortic repair; DIC: disseminated intravascular coagulation.
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Table 2
Summary of strategies for secondary aortoesophageal fistula.
Year Author [Reference] Number of cases Surgery of fistula Outocomes
2012 A. Saito et al. [4] Six cases (four after
TEVAR and two  after
open graft
replacement)
Five cases received staged surgery and one received
simultaneous it.
Two in-hospital deaths
(one case of staged surgery
and one of simultaneous it)
2012  M.  Amano et al. [7] One case after TAR Three staged surgery (first: esophagectomy and
esophagostomy, second: re-replacement, Third:
esophageal reconstruction)
Discharge
2013 H. Munakata et al. [8] One case after TEVAR Two staged surgery (First: aortic replacement,
















































2019 A. Kamigaichi et al. [9] One case after TEVAR Th
es
es
sophageal fistula. Xi et al. suggested that stent graft infection
hould be considered as the main mechanism of AEF formation [11].
n our 4 cases the progress after first surgery and the elapsed times
rom surgery to onset varied. Identifying the causes of AEF in any
onsistent manner is difficult.
Some papers suggested that combined surgery provided bet-
er outcomes for some patients of secondary AEF [7–9] (Table 2).
hat they suggested in common is that the first treatment of sec-
ndary AEF is infection control, with esophagectomy being the first
tage. The subsequent timing of second- and later-stage surgery
ust be judged by a comprehensive assessment of the degree of
mprovement with infection control and nutritional status. There
s the question of whether to replace an infected prosthetic graft.
here have been reports of an infective thoracic aortic aneurysm
nd artificial stent graft being removed and the aorta restored
n second-stage surgery [8,9]. These cases involved the first tho-
acotomy, whereas our cases involved the second one. This is a
arge difference. Infection may  be controlled by esophagectomy and
ntibiotic treatment, so we  think that prosthesis replacement is not
lways necessary. However, experience has shown that where a
rosthetic graft meets the native aorta, infection brings a real dan-
er of aneurysm. In case 2, TEVAR was done in the second stage as a
recaution, because the native aorta remained at the infected site.
In case 1, 2, and 3, a gastric tube was used to replace the
sophagus, and it was implanted in an antethoracic route. One
eason for this choice was the fact that anastomotic failure and
utaneous fistula formation occurred in all of 3 cases who under-
ent esophageal reconstruction. In the cases of AEF after prosthetic
eplacement, the upper or middle part of the esophagus is dam-
ged, and the esophagostoma to be formed in the first stage is on
he clavicle. The third-stage reconstruction has to bridge an unusu-
lly great distance, and we suspect that resulting mechanical stress
nd inadequate blood-flow led to anastomotic failure. Reconstruc-
ion methods need to be considered, for example selecting colon
econstruction.
. Conclusion
We  reported the clinical features and outcomes of treatment
f secondary AEF after prosthetic aortic replacement in 4 cases.
ased on our experience, the approach involving early diagnosis,
isruption of the infected fistula by esophagectomy, treatment of
rosthetic graft infection, prevention of possible pseudoaneurysm
ormation, and esophageal reconstruction, appears to be a valid
herapeutic strategy for secondary AEF.unding
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